NCT03263572
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein Expression, +29 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Explore clinical trials studying BCR-ABL1 Fusion Protein Expression. Study availability and eligibility vary by location and protocol.
NCT03263572
NCT00390793